Cancer drug futibatinib gets extended safety check in ongoing patients
NCT ID NCT06506955
First seen Mar 11, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study is for people with advanced or metastatic cancer who are already taking the drug futibatinib and benefiting from it. The goal is to keep giving them the drug while closely watching for side effects over a longer period. About 15 participants will join this rollover study to gather more safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED/METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Integral Oncologico
Madrid, 28050, Spain
-
Hospital Universitari, Vall d'Hebron
Barcelona, 8035, Spain
-
Institut De Cancerologie Strasbourg
Strasbourg, 67033, France
-
Institut Paoli-Calmettes
Marseille, 13009, France
-
Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
-
Sarah Cannon Research Institute UK
London, W1G 6AD, United Kingdom
-
Severance Hospital
Seoul, 3722, South Korea
-
University College London Hospitals NHS Foundation Trust
London, W1T 7HA, United Kingdom
-
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.